Abstract 926: Prolonged high fat dietary intake increases pancreatic intraepithelial neoplasia to cancer progression.
Abstract Background: Emerging evidence implicates dietary macronutrient composition as a key modulator of pancreatic tumorigenesis. While the high-fat diet (HFD) drives acinar-to-ductal metaplasia (ADM) and pancreatic intraepithelial neoplasia (PanIN) progression in KrasG12D mice, the impact of ketogenic diet (KD) remains controversial. To determine how KD affects early Kras-driven neoplasia, we investigated the effects of KD, HFD, and low-fat diet (LFD) on pancreatic disease initiation and progression using the Ptf1aCreERT2 KrasG12V (KCAcinar) mouse model. Methods: Six- to eight-week-old KCAcinar and wild-type (WT) mice were maintained on standard chow (SD) or switched to LFD, HFD, or KD for four weeks before tamoxifen-induced KrasG12V activation. Mice were monitored for survival, body weight, and glucose tolerance. Pancreatic tissues were collected for histopathological evaluation, trichrome staining, and immunohistochemistry. Reverse-phase protein array (RPPA) of pancreatic lysates and serum cytokine profiling were performed to assess signaling and systemic changes. Results: KD-fed KCAcinar mice showed the shortest survival (median 26 ± 7 days) compared with SD (87 ± 29; p = 0.02) and LFD (57 ± 27; p = 0.02), while HFD also reduced survival compared with SD (35 ± 25; p = 0.05). KD feeding induced glucose intolerance in both WT and KCAcinar mice. Histological analysis revealed that both KD- and HFD-fed KCAcinar mice developed a higher incidence of invasive PDAC with fibrosis, accompanied by reduced CD8+ T-cell infiltration and increased stromal CD39 expression relative to tumor compartments. Proteomic profiling showed increased Akt, phospho-S6, Paxillin, and YTHDF2, and decreased PUMA, STAT5A, PHGDH, FASN, and ASNS expression in KD- and HFD-fed KCAcinar mice. Pathway enrichment analysis identified upregulation of EGFR tyrosine kinase inhibitor resistance, chemokine, PI3K-Akt-mTOR, Rap1, and VEGF signaling pathways. Serum cytokine profiling further revealed elevated systemic levels of Ang-2, CCL6, LDLR MMP-9, PAI-1, PTX3, TNFSF13B, and OPG in KD-fed KCAcinar mice. Conclusions: Dietary lipid content before oncogenic Kras activation critically shapes pancreatic cancer development. Both ketogenic and high-fat diets accelerated progression from PanIN to invasive PDAC, accompanied by fibrosis, immune suppression, and activation of PI3K-Akt-mTOR and EGFR signaling. These findings reveal that lipid-rich diets can potentiate oncogenic and inflammatory pathways in the pancreas and caution against the use of ketogenic diets in prevention settings or early stages of pancreatic cancer. Citation Format: Urvinder Kaur Sardarni, Erika Y. Faraoni, Alyssa Waller, Lincoln Strickland, Baylee O'Brien, Jesse Cox, Florencia McAllister, Jennifer Bailey-Lundberg. Prolonged high fat dietary intake increases pancreatic intraepithelial neoplasia to cancer progression [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 926.
Authors
- Jennifer M. Bailey (ORCID: https://orcid.org/0000-0002-4750-106X)
- Jesse L. Cox (ORCID: https://orcid.org/0000-0002-4590-7381)
- Erika Y. Faraoni (ORCID: https://orcid.org/0000-0003-0731-2122)
- Urvinder Kaur Sardarni (ORCID: https://orcid.org/0000-0001-7984-3294)
- Lincoln N. Strickland (ORCID: https://orcid.org/0000-0002-2347-4431)
- Florencia McAllister (ORCID: https://orcid.org/0000-0002-9915-0943)
- AR Waller
- Baylee O'Brien
Institutions
- Nebraska Medical Center (US)
- The University of Texas MD Anderson Cancer Center (US)
- College Station Medical Center (US)
- University of Nebraska Medical Center (US)
- Texas A&M University (US)
Publication Details
- Journal
- Cancer Research
- Published
- 2026-04-03
- DOI
- https://doi.org/10.1158/1538-7445.am2026-926
- Primary Topic
- Cancer Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00